(Jacksonville, FL) - Each week more and more Top Professionals from the PGA, LPGA and Champions Tour are choosing to put a Cure Putter into play. This past weekend, at the AT&T Byron Nelson in Irving, TX, Robert Garrigus used a Cure CX Series putter to capture his first Top 10 Finish on the PGA Tour in two years.
Garrigus ranked T-2nd in birdies recorded with 22 at the AT&T Byron Nelson, including a run of 3 birdies in a row on 16, 17 and 18 to finish out the 2nd round. He finished at -13 under with a 1.671 Putts Per GIR average.
"Robert played some outstanding golf this past weekend at the Byron Nelson," said Jim McCarthy, CEO of Cure Putters. "We're very excited and proud to have a player of his caliber using our putter, and we'd like to congratulate him on his Top 5 Finish."
Cure Putters is a golf putter manufacturer based in Flagler Beach, Florida. Guided by the principle that "Form Follows Function", Cure Putters takes a no-nonsense, performance driven approach to putter design. Cure putters all feature an Extremely High MOI design, which is very stable and offers incredible forgiveness for much greater accuracy and distance control, even on extreme mishits. The adjustable weighting system allows a wide range of weight adjustability, allowing the golfer to find the perfect weight to suit their stroke and tempo. With a higher center of gravity, lower loft and deeper face that impacts the ball at the equator, Cure Putters deliver a superior roll - getting the ball rolling sooner, helping it stay on the intended line. Cure Putters' innovative design takes several problematic variables out of the equation and offers incredible forgiveness and control, resulting in a tighter shot dispersion. Golfers of every skill level will putt more consistently, build confidence and achieve better results with a Cure RX Series putter.
All Cure Putters are CNC milled from a solid block of T-6160 Aircraft Grade Aluminum and 100% Made and Assembled in the USA.
For more information on Cure Putters visit www.cureputters.com.